E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1 + Leukocyte Trafficking in Mice with Colitis

Published 2017 View Full Article

Authors

Keywords

Journal

MOLECULAR PHARMACOLOGY

Volume 92, Issue 5, Pages 502-509

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Online

2017-08-26

DOI

10.1124/mol.117.108381

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

MOLECULAR PHARMACOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer